Thierno Moussa Ndongo

Thierno Moussa NDONGO is a highly experienced lab manager currently employed at Egle Therapeutics since June 2024, previously holding the same title at Smartimmune from August 2022 to July 2024. Prior roles include Référent qualité technique at BIOGROUP from August 2020 to August 2022, where responsibilities involved managing technical quality documentation and audit preparations, as well as overseeing a team of molecular technologists in Covid-related operations. Thierno's earlier experiences include a trainee position at the Faculdade de Farmácia da Universidade do Porto, focusing on the inhibition effects of drugs related to Alzheimer’s disease, and a research internship at laboratoire MMS, studying transposable elements in insect resistance. Thierno holds multiple degrees from Le Mans Université, including a Master's in Toxicology and Ecotoxicology and a Master's in Management and Business Administration, along with a Bachelor's in Biochemistry and Molecular Biology, and an DUT in Chemical Engineering and Applied Biology from the école supérieure polytechnique de Dakar, Senegal.